# Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

> **NCT02322190** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 5 (actual)

## Conditions studied

- Chronic Graft vs. Host Disease
- Graft vs Host Disease
- Graft-Versus-Host Disease

## Interventions

- **PROCEDURE:** Extracorporeal Photopheresis (ECP)
- **DRUG:** Methoxsalen

## Key facts

- **NCT ID:** NCT02322190
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-20
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Due to slow/insufficient accrual and Principal Investigator left the NIH
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02322190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02322190, "Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02322190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*